MEGX test in hepatology: The long-sought ultimate quantitative liver function test?

Journal of Hepatology

Volumn 19, Issue 1, 1993, Pages 4-7

  Reichen, Jürg ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENAZONE; DEETHYLLIDOCAINE; LIDOCAINE;

EDITORIAL; HUMAN; LIVER FUNCTION TEST; PRIORITY JOURNAL;

HUMANS; LIDOCAINE; LIVER FUNCTION TESTS; METABOLIC CLEARANCE RATE; PREDICTIVE VALUE OF TESTS;

EID: 0027364211     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(05)80169-2     Document Type: Article

References (25)

1. Assessment of lidocaine metabolite formation in comparison with other liver function tests
2. Measuring lidocaine metabolite — monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis
3. Antipyrine, paracetamol and lignocaine elimination in chronic liver disease
4. Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis
5. Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic encephalopathy in cirrhotic patients following elective end-to-side portacaval shunt
6. Monoethylglycinexylidide formation kinetics: A novel approach to assessment of liver function
7. Lignocaine metabolite formation as a measure of pre-transplant liver function
8. Evaluation of quantitative liver function tests in liver donors
9. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis
10. Predictors of one-year pretransplant survival in patients with cirrhosis
11. Assessment of pretransplant prognosis in patients with cirrhosis
12. Assessment of lidocaine metabolite formation as a quantitative liver function test in children
13. Leberfunktionstests im klinischen Vergleich
14. The evolution of changes in quantitative liver function tests in a rat model of cirrhosis: Correlation with morphometric measurement of hepatocyte mass
15. Accurate prediction of death by serial determination of the galactose elimination capacity in primary biliary cirrhosis — A comparison with the Mayo model
16. Monoethylglycinexylide formation in assesing pediatric donor liver function
17. Clinical pharmacokinetics of lignocaine
18. A physiologic approach to hepatic drug clearance
19. Determinants of drug disposition in patients with cirrhosis
20. Severity of cirrhosis and the relationship of alpah l-acid glycorpotein concentration to plasma protein binding of lidocaine
21. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics
22. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4
23. Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients
24. Anaphylactoid reactions after indocyanine-green administration